News Snapshot:
China is in a global race to develop cost-effective vaccines to curb the COVID-19 pandemic. Beijing: China has approved human testing for a potential coronavirus vaccine cultivated within insect cells, local government in the southwestern city of Chengdu said on Saturday. China is in a global race to develop cost-effective vaccines to curb the COVID-19 pandemic. Using insect cells to grow proteins for the coronavirus vaccine – a first in China – could speed up large-scale production, the city government of Chengdu said in a notice on social media WeChat. The vaccine, developed by West China Hospital of Sichuan University...
